{"id":"W4409565762","doi":"10.1080/14796694.2025.2485015","title":"STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCC","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; Royal Ottawa Mental Health Centre","funders":"Exelixis; American Society of Clinical Oncology","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001786095,0.001243377,0.002345971,0.0004988722,0.000370572,0.0009994721,0.0008594278,0.001142794,0.00339808],"category_scores_gemma":[0.0006810539,0.00053924,0.001847372,0.0003131963,0.0009192374,0.0008320037,0.0003966293,0.002176811,0.001191833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001089527,"about_ca_system_score_gemma":0.002117348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001839983,"about_ca_topic_score_gemma":0.005610483,"domain_scores_codex":[0.9996095,0.0001836359,0.0000243049,0.00005953726,0.0000513683,0.00007169028],"domain_scores_gemma":[0.9995827,0.00005179306,0.00008137778,0.00002562461,0.00004446683,0.0002140529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8787318,0.02868056,0.002882553,0.001628856,0.002189168,0.00010019,0.0001805151,0.001952513,0.0217882,0.0003893438,0.003206532,0.05826991],"study_design_scores_gemma":[0.6845342,0.3008702,0.007672189,0.00008140439,0.000876242,0.0001320039,0.00008566907,0.001446703,0.001887387,0.0002779158,0.002102832,0.0000331895],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858578,0.004528056,0.0005381661,0.0005248616,0.0002663032,0.003708773,0.001178813,0.0001873055,0.003209915],"genre_scores_gemma":[0.9855959,0.002998779,0.001772986,0.001377423,0.0001757537,0.002818505,0.002216167,0.00003224623,0.003012321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00339808,"threshold_uncertainty_score":0.01136774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01271133484206635,"score_gpt":0.3210914434739092,"score_spread":0.3083801086318428,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}